Edition:
United Kingdom

Odonate Therapeutics Inc (ODT.OQ)

ODT.OQ on NASDAQ Stock Exchange Global Select Market

22.10USD
23 Jan 2018
Change (% chg)

-- (--)
Prev Close
$22.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$25.30
52-wk Low
$21.94

Chart for

About

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.61
EPS (TTM): -- -- --
ROI: -- 14.90 10.60
ROE: -- 16.40 14.19

BRIEF-Odonate Holdings Llc Reports A 11.5 Pct Stake In Odonate Therapeutics As Of Dec 6

* Reports A 11.5 Pct Stake In Odonate Therapeutics Inc AS OF DEC 6 - SEC FILING Source text: (http://bit.ly/2AU3onq) Further company coverage:

18 Dec 2017

BRIEF-Boxer Capital LLC Reports 10.0 Pct Stake In Odonate Therapeutics As Of Dec 6

* BOXER CAPITAL LLC REPORTS 10.0 PERCENT STAKE IN ODONATE THERAPEUTICS INC AS OF DECEMBER 6 - SEC FILING

08 Dec 2017

BRIEF-Odonate Therapeutics Announces Pricing Of Initial Public Offering

* ODONATE THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

07 Dec 2017

Earnings vs. Estimates